Title:
癌を治療するための生体影響性化合物の標的送達
Document Type and Number:
Japanese Patent JP2004532245
Kind Code:
A
Abstract:
A homogeneous conjugate for targeting and treating diseased cells wherein the conjugate comprises an anti-cancer drug and a targeting protein, wherein said anti-cancer drug is selected from the group consisting of heat sensitizers, photosensitizers and apoptosis inducing compounds, a method for making such a conjugate, and methods for using the conjugate. The targeting protein is preferably transferrin.
Inventors:
Fork page double
Application Number:
JP2002590988A
Publication Date:
October 21, 2004
Filing Date:
May 15, 2002
Export Citation:
Assignee:
Fork page double
International Classes:
A61K31/16; A61K31/195; A61K31/277; A61K31/282; A61K31/409; A61K31/495; A61K31/7028; A61K31/704; A61K31/714; A61K33/24; A61K33/26; A61K38/18; A61K38/31; A61K38/40; A61K41/00; A61K45/00; A61K47/48; A61P35/00; (IPC1-7): A61K47/48; A61K31/16; A61K31/195; A61K31/277; A61K31/282; A61K31/409; A61K31/704; A61K33/24; A61K33/26; A61K41/00; A61K45/00; A61P35/00
Domestic Patent References:
| JPS60501951A | 1985-11-14 | |||
| JPS63502747A | 1988-10-13 | |||
| JPH07505661A | 1995-06-22 | |||
| JPH06502177A | 1994-03-10 | |||
| JP2002095476A | 2002-04-02 | |||
| JP2004528309A | 2004-09-16 |
Other References:
JPN6008038998, Ａｎｔｉｃａｎｃｅｒ Ｒｅｓｅａｒｃｈ, 1994, Ｖｏｌ．１４，Ｎｏ．２Ａ, ｐ３９７−４０３
JPN5003018360, ＷＡＮＧ， Ｆ．, ＡＮＴＩＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, 2000, Ｖ２０Ｎ２Ａ, Ｐ７９９−８０８
JPN5003018361, ＦＡＵＬＫ， Ｗ．Ｐ．, ＭＯＬＥＣＵＬＡＲ ＢＩＯＴＨＥＲＡＰＹ, 1990, Ｖ２, Ｐ５７−６０
JPN6008039000, Ｊｏｕｒｎａｌ ｏｆ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｓｃｉｅｎｃｅｓ, 1998, Ｖｏｌ．８７，Ｎｏ．３, ｐ３３８−３４６
JPN6008039014, Ｂｉｏｃｈｅｍｉｃａｌ Ｐｈａｒｍａｃｏｌｏｇｙ, 1996, Ｖｏｌ．５１，Ｎｏ．４, ｐ４８９−４９３
JPN5003018360, ＷＡＮＧ， Ｆ．, ＡＮＴＩＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, 2000, Ｖ２０Ｎ２Ａ, Ｐ７９９−８０８
JPN5003018361, ＦＡＵＬＫ， Ｗ．Ｐ．, ＭＯＬＥＣＵＬＡＲ ＢＩＯＴＨＥＲＡＰＹ, 1990, Ｖ２, Ｐ５７−６０
JPN6008039000, Ｊｏｕｒｎａｌ ｏｆ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｓｃｉｅｎｃｅｓ, 1998, Ｖｏｌ．８７，Ｎｏ．３, ｐ３３８−３４６
JPN6008039014, Ｂｉｏｃｈｅｍｉｃａｌ Ｐｈａｒｍａｃｏｌｏｇｙ, 1996, Ｖｏｌ．５１，Ｎｏ．４, ｐ４８９−４９３
Attorney, Agent or Firm:
Daisuke Tanaka